ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

Amgen To Buy Mustafa Nevzat For $700 Million

Biotechnology firm Amgen (AMGN) will buy a 95.6% stake in Mustafa Nevzat Pharmaceuticals for $700 million, in a move to expand its presence in Turkey and the surrounding region. The all-cash transaction has been approved by both the boards, the two companies said in a joint statement Wednesday. MN, which supplies pharmaceuticals to the hospital sector and is a major supplier of injectable medicines in Turkey, had revenue of approximately $200 million in 2011, the statement said. Amgen's focus on Turkey and the surrounding region, which are large, fast-growing, priority markets for Amgen, is a part of its international expansion strategy. Amgen established an affiliate in Turkey in 2010 and currently markets two products, with plans to develop its pipeline of clinical candidates for Turkey and other markets around the world. Order free Annual Report for Amgen, Inc. Visit or call 1-888-301-0513

Stock News for Amgen Inc. (AMGN)
11/28/201515:41:02What Healthcare Dividend Stock Is Best?
11/28/201507:40:37Amgen Inc. Takes Aim at AbbVie Inc.
11/25/201516:00:00Amgen's First Biosimilar Biologics License Application For ABP...
11/25/201509:04:03Johnson & Johnson's Latest FDA Approval Could Spell Problems...
11/24/201508:38:03Healthcare's Greatest Dividend Stocks
11/24/201502:00:00European Commission Approves Amgen's BLINCYTO® (blinatumomab...
11/23/201508:50:00CVS Chooses New Cholesterol Drug for Caremark
11/23/201508:29:00CVS Chooses Repatha as New Cholesterol Drug for Caremark
11/23/201508:10:00Amgen Announces Repatha® Preferred Position On CVS Health Commercial...
11/21/201508:00:155 Things Amgen, Inc. Wants You to Know
11/20/201518:08:02The Best Healthcare ETF of the Week
11/20/201517:44:03Better Dividend Stock: Amgen or AstraZeneca PLC?
11/19/201516:00:00European Commission Approves Kyprolis® (carfilzomib) For Combination...
11/19/201510:03:08Amgen's Repatha Is Too Bloody Pricey for the U.K.
11/17/201509:42:033 Biotech Stocks You Don't Have to Babysit
11/17/201509:42:033 Biotech Stocks You Don't Have to Babysit
11/17/201509:42:033 Biotech Stocks You Don't Have to Babysit
11/17/201509:42:033 Biotech Stocks You Don't Have to Babysit
11/16/201516:00:00Amgen to Present IMLYGIC™ (Talimogene Laherparepvec) Data at t...
11/14/201507:21:02These 2 Companies Could Revolutionize Heart Disease Prevention

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations